Michael Amdahl
Overview
Explore the profile of Michael Amdahl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
567
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kirsch A, Lyko R, Nilsson L, Amdahl M, Lechner P, Schneider A, et al.
Nephrol Dial Transplant
. 2021 May;
36(8):1555-1556.
PMID: 34046683
No abstract available.
2.
Kirsch A, Lyko R, Nilsson L, Beck W, Amdahl M, Lechner P, et al.
Nephrol Dial Transplant
. 2016 Sep;
32(1):165-172.
PMID: 27587605
Background: Compared to high-flux dialysis membranes, novel medium cut-off (MCO) membranes show greater permeability for larger middle molecules. Methods: In two prospective, open-label, controlled, randomized, crossover pilot studies, 39 prevalent...
3.
Bernardo A, Marbury T, McFarlane P, Pauly R, Amdahl M, Demers J, et al.
Nephrol Dial Transplant
. 2016 May;
32(4):685-692.
PMID: 27190336
Background: The VIVIA Hemodialysis System (Baxter Healthcare Corporation, Deerfield, IL, USA) was designed for patient use at home to reduce the burden of treatment and improve patient safety. It has...
4.
Yan Y, Qian J, Chen N, Huang Z, Jiang G, Li X, et al.
Clin Nephrol
. 2013 Oct;
81(1):20-9.
PMID: 24131674
Aim: Prevalence of secondary hyperparathyroidism (SHPT), a renal disease complication, is increasing in China. Available therapies may not optimally control SHPT, particularly in patients with hypercalcemia, hyperphosphatemia, and parathyroid hyperplasia....
5.
Ketteler M, Martin K, Wolf M, Amdahl M, Cozzolino M, Goldsmith D, et al.
Nephrol Dial Transplant
. 2012 Mar;
27(8):3270-8.
PMID: 22387567
Background: Optimal treatment for secondary hyperparathyroidism (SHPT) has not been defined. The IMPACT SHPT (ClinicalTrials.gov identifier: NCT00977080) study assessed whether dose-titrated paricalcitol plus supplemental cinacalcet only for hypercalcaemia is superior...
6.
Ketteler M, Martin K, Cozzolino M, Goldsmith D, Sharma A, Khan S, et al.
Nephrol Dial Transplant
. 2011 Sep;
27(5):1942-9.
PMID: 21931122
Background: Paricalcitol and cinacalcet are common therapies for patients on haemodialysis with secondary hyperparathyroidism (SHPT). We conducted a multi-centre study in 12 countries to compare the safety and efficacy of...
7.
de Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyne D, Garimella T, et al.
Lancet
. 2010 Nov;
376(9752):1543-51.
PMID: 21055801
Background: Despite treatment with renin–angiotensin–aldosterone system (RAAS) inhibitors, patients with diabetes have increased risk of progressive renal failure that correlates with albuminuria. We aimed to assess whether paricalcitol could be...
8.
Lund R, Andress D, Amdahl M, Williams L, Heaney R
Am J Nephrol
. 2009 Dec;
31(2):165-70.
PMID: 20016142
Background/aims: Increased parathyroid activity associated with chronic kidney disease is often managed with calcitriol, which can elevate serum calcium (Ca) by increasing bone resorption and intestinal absorption, whereas paricalcitol promotes...
9.
Greenbaum L, Benador N, Goldstein S, Paredes A, Melnick J, Mattingly S, et al.
Am J Kidney Dis
. 2007 May;
49(6):814-23.
PMID: 17533024
Background: Secondary hyperparathyroidism is a common complication in children receiving hemodialysis. Active vitamin D is an effective therapy, but its use is often limited by hypercalcemia and increased calcium x...
10.
Dobrez D, Mathes A, Amdahl M, Marx S, Melnick J, Sprague S
Nephrol Dial Transplant
. 2004 Mar;
19(5):1174-81.
PMID: 15004264
Background: Abnormalities of serum calcium, phosphorous and intact parathyroid hormone (PTH) are associated with morbidity and mortality in haemodialysis patients. Pharmacologic parenteral vitamin D administration is used to correct these...